These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 37120265)
21. Anatomical and procedural determinants of ambulatory blood pressure lowering following catheter-based renal denervation using radiofrequency. Lauder L; Ewen S; Tzafriri AR; Edelman ER; Cremers B; Kulenthiran S; Ukena C; Linz D; Kindermann I; Tsioufis C; Scheller B; Böhm M; Mahfoud F Cardiovasc Revasc Med; 2018; 19(7 Pt B):845-851. PubMed ID: 29555535 [TBL] [Abstract][Full Text] [Related]
22. Renal denervation in moderate treatment-resistant hypertension. Ott C; Mahfoud F; Schmid A; Ditting T; Sobotka PA; Veelken R; Spies A; Ukena C; Laufs U; Uder M; Böhm M; Schmieder RE J Am Coll Cardiol; 2013 Nov; 62(20):1880-6. PubMed ID: 23850901 [TBL] [Abstract][Full Text] [Related]
23. Risk of resistant hypertension associated with restless legs syndrome and periodic limb movements during sleep: a study on 673 treated hypertensive individuals. Hein M; Lanquart JP; Hubain P; Loas G Sleep Med; 2019 Nov; 63():46-56. PubMed ID: 31606649 [TBL] [Abstract][Full Text] [Related]
24. Obesity predicts persistence of resistant hypertension after surgery in patients with primary aldosteronism. Nakamaru R; Yamamoto K; Rakugi H; Akasaka H; Kurihara I; Ichijo T; Takeda Y; Katabami T; Tsuiki M; Wada N; Ogawa Y; Kawashima J; Sone M; Yoshimoto T; Okamoto R; Fujita M; Kobayashi H; Tamura K; Kamemura K; Okamura S; Kakutani M; Tanabe A; Naruse M; Clin Endocrinol (Oxf); 2020 Sep; 93(3):229-237. PubMed ID: 32324297 [TBL] [Abstract][Full Text] [Related]
25. Anatomical eligibility of the renal vasculature for catheter-based renal denervation in hypertensive patients. Rimoldi SF; Scheidegger N; Scherrer U; Farese S; Rexhaj E; Moschovitis A; Windecker S; Meier B; Allemann Y JACC Cardiovasc Interv; 2014 Feb; 7(2):187-192. PubMed ID: 24440022 [TBL] [Abstract][Full Text] [Related]
26. Persistent Increase in Blood Pressure After Renal Nerve Stimulation in Accessory Renal Arteries After Sympathetic Renal Denervation. de Jong MR; Hoogerwaard AF; Gal P; Adiyaman A; Smit JJ; Delnoy PP; Ramdat Misier AR; van Hasselt BA; Heeg JE; le Polain de Waroux JB; Lau EO; Staessen JA; Persu A; Elvan A Hypertension; 2016 Jun; 67(6):1211-7. PubMed ID: 27113046 [TBL] [Abstract][Full Text] [Related]
27. The preservation of accessory renal arteries should be considered the treatment of choice in complex endovascular aortic repair. Torrealba JI; Kölbel T; Rohlffs F; Heidemann F; Spanos K; Panuccio G J Vasc Surg; 2022 Sep; 76(3):656-662. PubMed ID: 35276261 [TBL] [Abstract][Full Text] [Related]
28. Prevalence and clinical profile of refractory hypertension in a large cohort of patients with resistant hypertension. Chedier B; Cortez AF; Roderjan CN; Cavalcanti AH; Carlos FOC; Dos Santos BDM; Muxfeldt ES J Hum Hypertens; 2021 Aug; 35(8):709-717. PubMed ID: 32868882 [TBL] [Abstract][Full Text] [Related]
29. Optimum and stepped care standardised antihypertensive treatment with or without renal denervation for resistant hypertension (DENERHTN): a multicentre, open-label, randomised controlled trial. Azizi M; Sapoval M; Gosse P; Monge M; Bobrie G; Delsart P; Midulla M; Mounier-Véhier C; Courand PY; Lantelme P; Denolle T; Dourmap-Collas C; Trillaud H; Pereira H; Plouin PF; Chatellier G; Lancet; 2015 May; 385(9981):1957-65. PubMed ID: 25631070 [TBL] [Abstract][Full Text] [Related]
30. Correlation between Renal Artery Anatomy and Hypertension: A Retrospective Analysis of 3000 Patients. Shen J; Lyu L; Wu X; Ji J; Zeng C; Li S; Zhao Y; Xu J; Lin L; Lu C; Mao W; Wei T Evid Based Complement Alternat Med; 2021; 2021():9957361. PubMed ID: 35003315 [TBL] [Abstract][Full Text] [Related]
31. Marked sympathetic activation and baroreflex dysfunction in true resistant hypertension. Grassi G; Seravalle G; Brambilla G; Pini C; Alimento M; Facchetti R; Spaziani D; Cuspidi C; Mancia G Int J Cardiol; 2014 Dec; 177(3):1020-5. PubMed ID: 25449517 [TBL] [Abstract][Full Text] [Related]
32. Current Status of Renal Artery Angioplasty and Stenting for Resistant Hypertension: A Case Series and Review of the Literature. Manolis AS; Manolis AA; Melita H Curr Hypertens Rev; 2017; 13(2):93-103. PubMed ID: 28782466 [TBL] [Abstract][Full Text] [Related]
33. Results of a retrospective, observational pilot study using electronic medical records to assess the prevalence and characteristics of patients with resistant hypertension in an ambulatory care setting. McAdam-Marx C; Ye X; Sung JC; Brixner DI; Kahler KH Clin Ther; 2009 May; 31(5):1116-23. PubMed ID: 19539112 [TBL] [Abstract][Full Text] [Related]
34. Altered renal functions in patients with occlusion of an accessory renal artery after endovascular stenting of an infrarenal aneurysm. Sadeghi-Azandaryani M; Zimmermann H; Korten I; Klose A; Scheiermann P; Treitl M; Heyn J J Vasc Surg; 2017 Mar; 65(3):635-642. PubMed ID: 28029565 [TBL] [Abstract][Full Text] [Related]
35. Clinical effect of accessory renal artery coverage after endovascular repair of aneurysms in abdominal and thoracoabdominal aorta. Spanos K; Nana P; Brotis AG; Kouvelos G; Behrendt CA; Tsilimparis N; Kölbel T; Matsagkas M; Giannoukas A J Vasc Surg; 2021 Dec; 74(6):2104-2113.e7. PubMed ID: 34197943 [TBL] [Abstract][Full Text] [Related]
36. Prevalence and associated factors of obstructive sleep apnea in refractory hypertension. Chedier B; Roderjan CN; Cavalcanti AH; de Souza F; Muxfeldt ES J Hypertens; 2022 Jul; 40(7):1327-1335. PubMed ID: 35762473 [TBL] [Abstract][Full Text] [Related]
37. A controlled trial of renal denervation for resistant hypertension. Bhatt DL; Kandzari DE; O'Neill WW; D'Agostino R; Flack JM; Katzen BT; Leon MB; Liu M; Mauri L; Negoita M; Cohen SA; Oparil S; Rocha-Singh K; Townsend RR; Bakris GL; N Engl J Med; 2014 Apr; 370(15):1393-401. PubMed ID: 24678939 [TBL] [Abstract][Full Text] [Related]
38. Cardiovascular morbidity of severe resistant hypertension among treated uncontrolled hypertensives: a 4-year follow-up study. Kasiakogias A; Tsioufis C; Dimitriadis K; Konstantinidis D; Koumelli A; Leontsinis I; Andrikou E; Vogiatzakis N; Marinaki S; Petras D; Fragoulis C; Konstantinou K; Papademetriou V; Tousoulis D J Hum Hypertens; 2018 Jul; 32(7):487-493. PubMed ID: 29713047 [TBL] [Abstract][Full Text] [Related]
39. [Renal denervation a treatment for resistant hypertension: a French experience]. Benamer H; Mylotte D; Garcia-Alonso C; Unterseeh T; Garot P; Louvard Y; Lefevre T; Morice MC; Ann Cardiol Angeiol (Paris); 2013 Dec; 62(6):384-91. PubMed ID: 24182849 [TBL] [Abstract][Full Text] [Related]
40. Does the presence of accessory renal arteries affect the efficacy of renal denervation? Id D; Kaltenbach B; Bertog SC; Hornung M; Hofmann I; Vaskelyte L; Sievert H JACC Cardiovasc Interv; 2013 Oct; 6(10):1085-91. PubMed ID: 24156968 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]